EEB: Mutational Signatures in cancer: Clinical Implications
Mutational Signatures in cancer: Clinical Implications
 |
 |
|---|---|
|
Speaker:
Fei Dong, MD |
Moderator:
Kurtis Davies, MD |
Description:
This microlearning module discusses the Clinical Implications of the recent and relevant research on Mutational Signatures in cancer. It is part of the Emerging and Evolving Biomarkers: Mutational Signatures in cancer webinar.
This program has been supported through educational grant funding provided by Amgen and Loxo Oncology at Lilly (for further information concerning Lilly grant funding visit www.lillygrantoffice.com.) Supporting companies had no control over its content. No personally-identifiable information regarding you is provided to any grant supporters.
Note: Join the AMP Family for discounted access to the most current educational resources!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation.